Flavivirus DNA Vaccines
- 1 December 2001
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 951 (1) , 272-285
- https://doi.org/10.1111/j.1749-6632.2001.tb02703.x
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Chimeric Dengue Type 2 (Vaccine Strain PDK-53)/Dengue Type 1 Virus as a Potential Candidate Dengue Type 1 Virus VaccineJournal of Virology, 2000
- A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in miceVaccine, 2000
- Recombinant, chimaeric live, attenuated vaccine (ChimeriVax™) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primatesVaccine, 1999
- DNA VACCINESAnnual Review of Immunology, 1997
- Immunisation with DNA polynucleotides protects mice against lethal challenge with St. Louis encephalitis virusArchiv für die gesamte Virusforschung, 1996
- Expression of cloned envelope protein genes from the flavivirus tick-borne encephalitis virus in mammalian cells and random mutagenesis by PCRVirus Genes, 1994
- FLAVIVIRUS GENOME ORGANIZATION, EXPRESSION, AND REPLICATIONAnnual Review of Microbiology, 1990
- Development of Dengue and Japanese Encephalitis VaccinesThe Journal of Infectious Diseases, 1990
- Epitope Mapping of Japanese Encephalitis Virus Envelope Protein Using Monoclonal Antibodies against an Indian StrainJournal of General Virology, 1988
- Signal sequencesJournal of Molecular Biology, 1985